Abbott Laboratories (ABT) Stock Price

Currency:

Abbott Laboratories Price

🇺🇸NYSE·CLOSED

108.67USD

Market closed

Today +/-

+null USD

Today %

+null %

PRO

Abbott Laboratories (ABT) — ISIN US0028241000. The Abbott Laboratories stock price was 108.67 USD in 2026. Revenue was 48.28 B USD. Earnings were 10.04 B USD. P/E ratio was 18.92. Abbott Laboratories operates in the Health sector.

Abbott Laboratories stock price

Ex-Dividend

Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Abbott Laboratories over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Abbott Laboratories stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Abbott Laboratories's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Abbott Laboratories Stock Price History

Date	Abbott Laboratories Price
3/6/2026	108.67 USD
3/5/2026	110.84 USD
2/27/2026	115.89 USD
2/26/2026	116.27 USD
2/25/2026	115.09 USD
2/24/2026	114.27 USD
2/23/2026	115.07 USD
2/20/2026	112.51 USD
2/19/2026	111.91 USD
2/18/2026	113.30 USD
2/17/2026	112.72 USD
2/13/2026	112.31 USD
2/12/2026	111.21 USD
2/11/2026	113.21 USD
2/10/2026	112.51 USD
2/9/2026	111.01 USD
2/6/2026	110.46 USD
2/5/2026	109.14 USD

API Docs Get API Key

Abbott Laboratories Revenue, EBIT, Net Income

3 Years
5 Years
10 Years
25 Years
Max

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

Revenue

EBIT

Net Income

Details

API Docs Get API Key

Abbott Laboratories Income Statement, Balance Sheet, Cash Flow Statement

Last updated Mar 7, 2026, 7:04 AM

REVENUE (B USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (B USD)

NET INCOME (B USD)

NET INCOME GROWTH (%)

DIVIDEND (USD)DIV. (USD)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (B)

DOCUMENTS

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e	2027e	2028e	2029e	2030e	2031e
2.93	3.1	3.36	3.81	4.39	4.94	5.38	6.16	6.88	7.85	8.41	9.16	10.01	11.01	11.89	12.51	13.18	13.75	16.29	15.28	17.28	19.68	22.34	22.48	25.91	29.53	30.77	35.17	21.41	19.05	19.66	20.25	20.41	20.85	27.39	30.58	31.9	34.61	43.08	43.65	40.11	41.95	44.33	48.28	51.85	55.45	59.18	63.47	67.63
–	6.01	8.25	13.33	15.23	12.51	8.97	14.48	11.66	14.18	7.08	8.90	9.35	10.00	7.95	5.24	5.32	4.31	18.47	-6.17	13.09	13.89	13.50	0.62	15.30	13.94	4.19	14.31	-39.13	-11.01	3.19	3.00	0.78	2.20	31.35	11.64	4.34	8.48	24.47	1.34	-8.12	4.59	5.67	8.92	7.39	6.93	6.74	7.25	6.55
48.16	49.58	49.55	50.92	52.10	52.34	52.47	52.75	54.34	55.36	56.17	56.38	56.79	57.03	57.51	56.79	54.64	54.61	52.42	55.36	55.01	54.85	52.36	56.33	55.92	57.29	57.06	58.30	53.00	53.29	53.23	54.57	57.22	56.43	54.74	58.50	58.64	56.75	57.07	56.28	55.32	55.56	56.72	52.08	48.49	45.35	42.49	39.62	37.18
1.41	1.54	1.67	1.94	2.29	2.58	2.82	3.25	3.74	4.35	4.72	5.16	5.69	6.28	6.84	7.11	7.2	7.51	8.54	8.46	9.51	10.8	11.7	12.66	14.49	16.92	17.56	20.5	11.35	10.15	10.46	11.05	11.68	11.77	14.99	17.89	18.71	19.64	24.59	24.57	22.19	23.31	25.15	25.15	25.15	25.15	25.15	25.15	25.15
0.35	0.4	0.47	0.54	0.63	0.75	0.86	0.97	1.09	1.24	1.4	1.52	1.69	1.88	2.08	2.33	2.45	2.79	1.55	2.79	2.75	3.24	3.37	1.72	3.61	4.88	5.75	4.63	4.73	5.96	2.58	2.28	4.42	1.4	0.48	2.37	3.69	4.5	7.07	6.93	5.72	13.4	6.52	10.04	11.05	12.1	12.99	14.76	16.08
–	15.80	15.38	16.13	17.22	18.80	14.36	12.33	12.73	13.77	12.91	8.43	11.34	11.43	10.47	12.27	4.80	13.90	-44.36	80.26	-1.47	17.51	4.23	-49.08	110.02	35.33	17.75	-19.49	2.20	26.12	-56.80	-11.34	93.65	-68.35	-65.93	396.44	55.70	21.91	57.31	-1.95	-17.45	134.18	-51.32	53.94	10.03	9.46	7.37	13.67	8.89
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.16	1.27	1.40	1.56	1.72	1.88	2.01	0.70	1.10	0.96	1.04	1.33	1.12	1.60	1.44	1.80	1.88	2.04	2.20	2.36	0.63	3.06	3.37	-	-	-
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	9.48	10.24	11.43	10.26	9.30	6.91	-65.17	57.14	-12.73	8.33	27.88	-15.79	42.86	-10.00	25.00	4.44	8.51	7.84	7.27	-73.31	385.71	10.13	–	–	–
1.95	1.93	1.92	1.87	1.82	1.81	1.79	1.74	1.71	1.69	1.66	1.62	1.61	1.58	1.58	1.56	1.56	1.57	1.57	1.57	1.57	1.57	1.56	1.54	1.56	1.56	1.56	1.56	1.57	1.59	1.57	1.53	1.51	1.48	1.75	1.77	1.78	1.79	1.79	1.76	1.75	1.75	1.75	1.75	1.75	1.75	1.75	1.75	1.75
–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Abbott Laboratories generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Abbott Laboratories retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Abbott Laboratories's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Abbott Laboratories has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Abbott Laboratories's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ASSETS

CASH BALANCE (B USD)

RECEIVABLES (B USD)

OTHER RECEIVABLES (M USD)OTHER REC. (M USD)

INVENTORIES (B USD)

OTHER CURRENT ASSETS (B USD)OTHER CURRENT LIAB. (B USD)

CURRENT ASSETS (B USD)

TANGIBLE ASSETS (B USD)

LONG-TERM INVESTMENTS (B USD)LONG-T. INVEST. (B USD)

LONG-TERM RECEIVABLES (M USD)LONG-T. REC. (M USD)

INTANGIBLE ASSETS (B USD)INTANGIBLE ASSETS (B USD)

GOODWILL (B USD)

OTHER NON-CURRENT ASSETS (B USD)OTHER NON-CURRENT ASSETS (B USD)

NON-CURRENT ASSETS (B USD)

TOTAL ASSETS (B USD)

LIABILITIES

COMMON STOCK (B USD)

ADDITIONAL PAID-IN CAPITAL (M USD)

RETAINED EARNINGS (B USD)

OTHER EQUITY (B USD)OTHER EQUITY (B USD)

UNREALIZED GAINS/LOSSES (M USD)UNREAL. GAINS/LOSSES (M USD)

EQUITY (B USD)

LIABILITIES (B USD)

PROVISIONS (B USD)

OTHER SHORT-TERM LIABILITIES (B USD)OTHER SHORT-TERM LIAB. (B USD)

SHORT-TERM DEBTS (B USD)SHORT-TERM DEBTS (B USD)

SHORT-TERM PORTION OF LONG-TERM DEBTS (B USD)LONG-TERM DEBT PORTION (B USD)

SHORT-TERM RECEIVABLES (B USD)SHORT-TERM REC. (B USD)

LONG-TERM LIABILITIES (B USD)LONG-T. LIAB. (B USD)

DEFERRED TAXES (B USD)

OTHER LIABILITIES (B USD)OTHER LIAB. (B USD)

LONG-TERM LIABILITIES (B USD)LONG-T. LIABILITIES (B USD)

DEBT (B USD)

TOTAL CAPITAL (B USD)

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

0.21	0.45	0.44	0.48	0.52	0.58	0.05	0.05	0.15	0.26	0.38	0.32	0.32	0.12	0.29	0.41	0.72	1.16	0.71	0.97	1.29	2.06	2.96	1.37	2.82	5.08	9.93	5.45	8.1	15.17	8.1	4.46	6.13	18.78	9.61	4.09	4.14	7.15	10.25	10.17	7.28	7.97
0.48	0.49	0.56	0.62	0.73	0.78	0.89	1.07	1.15	1.24	1.34	1.47	1.56	1.71	1.78	1.96	2.06	2.18	2.81	2.93	3.31	3.7	3.58	4.23	4.95	5.47	6.54	7.18	7.68	7.61	3.99	3.59	3.42	3.25	5.25	5.18	5.43	6.41	6.49	6.22	6.57	6.93
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.43	0.43	0.46	0.52	0.61	0.61	0.7	0.78	0.82	0.86	0.94	1.02	1.11	1.24	1.28	1.41	1.5	1.74	2.21	2.44	2.74	2.62	2.54	2.81	2.95	2.78	3.26	3.19	3.28	3.79	2.69	2.64	2.6	2.43	3.6	3.8	4.32	5.01	5.16	6.17	6.57	6.19
0.17	0.18	0.22	0.26	0.3	0.38	0.47	0.56	0.78	0.87	0.93	1.07	1.24	1.41	1.72	1.81	2.15	2.3	2.68	2.12	2.28	2.36	2.31	2.87	3.32	3.72	3.58	6.49	4.7	4.74	4.47	2.87	2.01	2.32	1.69	1.57	1.79	1.87	2.35	2.66	2.26	2.57
1.29	1.55	1.68	1.89	2.16	2.35	2.1	2.46	2.89	3.23	3.59	3.88	4.23	4.48	5.08	5.59	6.42	7.38	8.42	8.46	9.61	10.73	11.39	11.28	14.04	17.04	23.31	22.32	23.77	31.32	19.25	13.56	14.16	26.78	20.15	14.63	15.67	20.44	24.24	25.22	22.67	23.66
1.07	1.24	1.37	1.54	1.74	1.95	2.09	2.38	2.66	3.1	3.51	3.92	4.25	4.46	4.57	4.74	4.77	4.82	5.55	5.83	6.28	6.01	6	6.95	7.52	7.22	7.62	7.97	7.87	8.06	5.91	5.94	5.73	5.71	7.61	7.56	8.97	10.13	10.11	10.28	11.28	11.73
0.4	0.33	0.28	0.25	0.29	0.29	0.3	0.31	0.34	0.27	0.22	0.32	0.42	0.67	0.76	0.97	0.95	0.64	0.65	0.25	0.41	0.15	0.13	1.23	1.13	1.07	0.25	0.3	0.38	0.27	0.12	0.23	4.04	2.95	0.88	0.9	0.88	0.82	0.82	0.77	0.8	0.89
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	880	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0.15	0.16	0.98	1.11	1.35	1.57	0.89	4.12	3.92	4.09	5.17	4.74	6.4	5.72	5.15	6.29	12.15	9.99	8.59	5.74	6.2	5.56	4.54	21.47	18.94	17.03	14.78	12.74	10.45	8.82	6.65
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.66	3.18	3.73	4.45	5.69	5.22	9.45	10.13	9.99	13.2	15.93	15.71	15.77	9.77	10.07	9.64	7.68	24.02	23.25	23.2	23.74	23.23	22.8	23.68	23.11
0.06	0.06	0.14	0.18	0.2	0.23	0.36	0.41	0.36	0.34	0.37	0.26	0.36	0.54	0.58	0.61	0.75	0.9	1.38	1.41	1.2	1.02	1.66	0.87	1.18	1.95	1.02	1.9	2.56	3.21	2.18	5.22	2.12	5.02	2.12	1.89	2.15	2.63	4.06	4.92	5.98	15.38
1.53	1.62	1.79	1.98	2.23	2.47	2.75	3.1	3.36	3.71	4.1	4.65	5.19	6.64	7.03	7.67	8.05	7.91	14.88	15.14	16.42	18.03	17.76	24.9	25.67	25.38	29.27	38.26	36.51	35.91	23.71	27.65	27.09	25.89	56.1	52.54	52.22	52.11	50.96	49.21	50.54	57.76
2.82	3.17	3.47	3.87	4.39	4.83	4.85	5.56	6.26	6.94	7.69	8.52	9.41	11.13	12.1	13.26	14.47	15.28	23.3	23.59	26.04	28.77	29.14	36.18	39.71	42.42	52.58	60.57	60.28	67.24	42.95	41.21	41.25	52.67	76.25	67.17	67.89	72.55	75.2	74.44	73.21	81.41

0.18	0.19	0.19	0.18	0.19	0.21	0.24	0.3	0.36	0.44	0.47	0.51	0.58	0.69	0.99	1.31	1.94	2.22	2.64	2.89	3.03	3.19	3.48	4.29	6.1	7.44	8.26	8.74	9.82	11.76	12.05	12.38	12.73	13.03	23.21	23.51	23.85	24.15	24.47	24.71	24.87	25.15
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.4	1.65	1.84	1.7	1.93	2.27	2.53	2.53	2.87	2.99	3.36	3.65	3.93	4.26	4.36	4.74	6.17	7.23	7.28	8.6	9.69	10.03	10.4	9.57	10.81	13.83	17.34	19.22	20.91	24.15	21.98	22.87	25.76	25.57	23.98	24.56	25.85	27.63	31.53	35.26	37.55	47.26
-0.06	-0.08	-0.06	-0.03	0.04	0.04	0.01	0.06	0.03	-0.03	-0.11	-0.06	-0.06	-0.09	-0.26	-0.25	-0.43	-0.62	-0.61	-0.6	0.58	1.32	0.75	0.39	2.08	-1.16	0.85	-1.37	-2.6	-3.63	-2.03	-5.05	-6.72	-7.19	-6.06	-7.59	-8.47	-8.95	-8.37	-8.05	-7.84	-7.91
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31	13	1	65	-69	-5	0	0	0	0	0	0	0
1.53	1.75	1.97	1.86	2.15	2.52	2.78	2.89	3.26	3.4	3.73	4.1	4.45	4.87	5.08	5.8	7.69	8.83	9.31	10.9	13.3	14.55	14.63	14.25	18.99	20.11	26.45	26.59	28.13	32.31	32.02	30.2	31.83	31.33	41.12	40.49	41.24	42.83	47.62	51.92	54.58	64.51
0.17	0.15	0.2	0.19	0.23	0.27	0.31	0.35	0.52	0.6	0.64	0.67	0.76	0.92	1	1.06	1.23	1.36	1.53	1	1.08	1.05	1.03	1.18	1.22	1.35	1.28	1.54	1.72	1.8	1.03	1.06	1.08	1.18	2.4	2.98	3.25	3.95	4.41	4.61	4.3	4.2
0.25	0.26	0.32	0.35	0.41	0.46	0.56	0.66	0.86	1.1	1.15	1.41	1.5	1.53	1.74	1.76	1.82	1.95	2.84	2.78	2.81	3.13	3.35	4.66	4.57	5.23	5.52	7.34	9.12	8.21	4.41	3.65	3.77	3.25	4.79	4.87	5.18	6.58	6.81	7.4	7.02	6.84
0.1	0.12	0.14	0.18	0.25	0.22	0.22	0.32	0.3	0.17	0.46	0.62	0.48	0.51	0.51	0.39	0.58	0.51	0.6	0.41	0.54	0.65	0.97	0.72	0.58	2.28	1.06	1.99	1.27	1.5	1.41	1.76	1.64	1.36	1	0.96	0.95	1.16	1.14	1.23	1.45	1.62
0.15	0.27	0.11	0.59	0.6	0.49	0.11	0.65	0.52	0.91	0.84	0.75	1.05	1.38	1.78	1.76	0.9	0.23	2.95	1.93	0.83	1.84	0.21	5.31	1.83	1.69	4.98	4.35	2.35	1.47	2.66	3.94	2.69	0.87	0.21	0.2	0.2	0.21	0	0	0	0
0	0	0.01	0.01	0.01	0	0.19	0.01	0.02	0.01	0	0.02	0	0	0	0	0	0.25	0	0.22	1.71	0.16	1.85	0.1	0.9	1.04	0.21	2.04	1.03	0.31	0.01	0.06	0	0	0.51	0.01	1.28	0.01	0.75	2.25	1.08	1.5
0.67	0.8	0.79	1.3	1.49	1.44	1.38	2	2.23	2.78	3.09	3.48	3.79	4.34	5.04	4.97	4.52	4.3	7.93	6.34	6.96	6.83	7.42	11.95	9.1	11.59	13.05	17.26	15.48	13.28	9.51	10.47	9.19	6.66	8.91	9.01	10.86	11.91	13.11	15.49	13.84	14.16
0.48	0.47	0.44	0.3	0.27	0.35	0.15	0.13	0.13	0.11	0.31	0.29	0.44	0.93	0.94	1.34	1.34	1.08	4.34	4.27	3.45	4.79	4.57	7.01	9.49	8.71	11.27	12.52	12.04	18.09	3.39	3.39	5.87	20.68	27.21	19.36	16.12	18.53	17.3	14.52	13.6	12.63
0.16	0.2	0.25	0.35	0.37	0.4	0.44	0.41	0.35	0.32	0.05	0.06	0.07	0.15	0.14	0.11	0.02	0	0	0	0	0.22	0.58	0	0	0	0.17	1.11	0.7	0.71	0.47	0.87	0.81	0.36	2.01	2.06	1.55	1.41	1.39	0.99	0.57	0.51
0.09	0.09	0.11	0.14	0.17	0.17	0.16	0.18	0.35	0.38	0.56	0.66	0.72	0.88	0.95	1.09	1.17	1.34	1.97	2.32	2.55	2.61	2.16	3.16	3.34	4.6	4.91	6.91	7.53	8.35	4.33	4.84	4.06	4.25	7.02	6.02	8.06	7.71	7.38	6.53	6.38	6.22
0.73	0.76	0.81	0.78	0.81	0.92	0.74	0.73	0.82	0.81	0.92	1	1.23	1.96	2.03	2.54	2.53	2.41	6.31	6.59	6	7.62	7.31	10.17	12.83	13.31	16.34	20.55	20.27	27.14	8.18	9.1	10.74	25.29	36.24	27.44	25.72	27.64	26.07	22.04	20.55	19.36
1.4	1.57	1.6	2.09	2.29	2.36	2.13	2.73	3.05	3.59	4.01	4.47	5.02	6.31	7.07	7.51	7.04	6.71	14.24	12.93	12.97	14.44	14.73	22.12	21.94	24.9	29.39	37.81	35.75	40.42	17.69	19.57	19.92	31.95	45.15	36.45	36.59	39.55	39.17	37.53	34.39	33.51
2.93	3.32	3.57	3.94	4.45	4.89	4.91	5.62	6.31	6.99	7.74	8.58	9.46	11.18	12.15	13.31	14.73	15.54	23.55	23.82	26.27	28.99	29.35	36.37	40.93	45.01	55.85	64.4	63.88	72.73	49.7	49.77	51.75	63.28	86.27	76.94	77.82	82.37	86.8	89.45	88.97	98.02

Details

Balance Sheet

ⓘ

What Is the Balance Sheet?

The balance sheet is a financial snapshot of Abbott Laboratories at a specific point in time. It follows the fundamental equation: Assets = Liabilities + Shareholders' Equity. Unlike the income statement (which covers a period), the balance sheet tells you what the company owns, what it owes, and what belongs to shareholders at a given date.

Assets

Current assets (cash, receivables, inventory) can be converted to cash within 12 months and indicate short-term liquidity. Non-current assets (property, equipment, intangible assets, goodwill) represent long-term investments. A high proportion of cash and short-term investments gives Abbott Laboratories financial flexibility to weather downturns, fund acquisitions, or return capital to shareholders.

Liabilities

Current liabilities (accounts payable, short-term debt) are obligations due within one year. Non-current liabilities (long-term debt, pension obligations) are due further out. Key ratio to watch: the debt-to-equity ratio (Total Debt ÷ Shareholders' Equity). A ratio below 1.0 is generally healthy, meaning the company is funded more by equity than debt. Highly leveraged companies amplify both gains and losses.

Shareholders' Equity

Equity is the residual value belonging to shareholders after all debts are paid. It includes retained earnings (accumulated profits not paid out as dividends) and paid-in capital. Rising equity year over year is a positive sign — it means Abbott Laboratories is building book value. Declining equity, especially when driven by losses or heavy share buybacks funded by debt, warrants closer scrutiny.

Key Ratios to Derive

From the balance sheet, you can calculate the current ratio (current assets ÷ current liabilities; above 1.5 is comfortable), book value per share (equity ÷ shares outstanding), and return on equity (net income ÷ equity; above 15 % is strong). Tracking these ratios over time reveals whether Abbott Laboratories is strengthening or weakening its financial position.

NET INCOME (B USD)

DEPRECIATION AND AMORTIZATION B USDDEPRECIATION (B USD)

DEFERRED TAXES (M USD)

CHANGES IN WORKING CAPITAL (B USD)CHANGES IN WORKING CAPITAL (B USD)

NON-CASH ITEM (B USD)

PAID INTEREST (M USD)

PAID TAXES (B USD)

Net Cash Flow from Operating Activities (B USD)NET CASH FLOW FROM OPERATING ACTIVITIES (B USD)

CAPITAL EXPENDITURES (M USD)

CASH FLOW FROM INVESTING ACTIVITIES (M USD)CASH FLOW FROM INVESTING ACTIVITIES (M USD)

CASH FLOW FROM OTHER INVESTING ACTIVITIES (B USD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (B USD)

INTEREST INCOME AND EXPENSES (M USD)

NET DEBT CHANGE (B USD)NET DEBT CHANGE (B USD)

Net change in equity (M USD)NET CHANGE IN EQUITY (M USD)

CASH FLOW FROM FINANCING ACTIVITIES (B USD)CASH FLOW FROM FINANCING ACTIVITIES (B USD)

OTHER ITEMS OF FINANCING CASH FLOWS (USD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (USD)

TOTAL DIVIDENDS PAID (M USD)

NET CHANGE IN CASH FLOW (B USD)

FREE CASH FLOW (M USD)

SHARE-BASED COMPENSATION (M USD)

1983	1984	1985	1986	1987	1988	1989	1990	1991	1992	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
0.35	0.4	0.47	0.54	0.63	0.75	0.86	0.97	1.09	1.24	1.4	1.52	1.69	1.88	2.08	2.33	2.45	2.79	1.55	2.79	2.75	3.24	3.37	1.72	3.61	4.88	5.75	4.63	4.73	5.96	2.58	2.28	4.42	1.4	0.48	2.37	3.69	4.5	7.07	6.93	5.72	13.4
0.1	0.13	0.16	0.2	0.24	0.27	0.31	0.36	0.38	0.43	0.48	0.51	0.57	0.69	0.73	0.79	0.83	0.83	1.17	1.04	1.13	1.29	1.36	1.56	1.85	1.84	2.09	2.62	3.04	2.78	1.72	1.55	1.47	1.35	3.02	3.28	3.01	3.33	3.54	3.27	3.24	3.22
56	47	62	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-0.05	0.01	-0.1	0.02	-0.01	-0.09	-0.21	-0.11	-0.06	-0.28	-0	0.15	-0.34	-0.24	-0.29	-0.34	-0.33	-0.45	-0.64	-0.14	-0.42	-0.51	0.14	-0.55	-1.06	-0.04	-0.34	0.66	0	-1.86	-1.24	-0.49	-0.16	-1.51	1.92	-0.15	-1.33	-0.89	-0.77	-1.52	-2.48	-9.22
-0.03	-0.03	0.03	0	0.02	0.03	0.01	-0.01	0.05	0	-0.03	0.03	0.05	0.05	0.15	0.09	0.09	-0.07	1.49	0.29	0.29	1.1	0.3	2.93	1.22	1.01	0.15	1.21	1.58	2.86	0.53	0.58	-2.48	2.27	0.56	1.28	1.29	1.52	1.34	1.59	1.41	1.83
0	0	0	95	76	85	74	94	59	58	52	50	67	89	132	153	145	113	232	265	207	197	213	428	563	561	514	580	545	576	148	182	166	181	917	845	677	549	544	563	662	604
0	0	0	0.15	0.24	0.36	0.36	0.34	0.65	0.7	0.33	0.57	0.95	0.8	0.92	1.06	0.88	1.09	0.98	0.88	0.83	0.68	0.75	1.28	0.95	0.77	0.64	0.81	1.78	1.37	1.04	0.45	0.63	0.62	0.57	0.74	0.93	0.97	1.94	1.86	1.48	1.72
0.43	0.56	0.62	0.76	0.89	0.97	0.96	1.2	1.45	1.39	1.85	2.21	1.97	2.38	2.66	2.88	3.04	3.1	3.57	3.99	3.75	5.11	5.17	5.33	5.18	7.34	7.28	8.74	8.97	9.31	3.32	3.68	2.97	3.2	5.57	6.3	6.14	7.9	10.53	9.58	7.26	8.56
-300	-320	-270	-383	-432	-521	-573	-641	-770	-1,007	-952	-929	-947	-949	-1,009	-993	-987	-1,035	-1,163	-1,105	-1,050	-1,291	-1,207	-1,337	-1,656	-1,287	-1,089	-1,015	-1,491	-1,795	-1,145	-1,077	-1,110	-1,121	-1,135	-1,394	-1,638	-2,177	-1,885	-1,777	-2,202	-2,207
-300	-320	-270	-319	-527	-431	-392	-618	-642	-667	-793	-944	-1,037	-1,955	-1,241	-1,481	-1,233	-617	-8,384	-1,690	-1,630	-3,923	-720	-11,397	-1,136	-2,087	-3,698	-12,188	661	-5,560	-3,929	-202	406	-248	-9,618	-1,356	-1,815	-2,215	-2,008	-1,740	-3,133	-2,338
0	0	0	0.06	-0.09	0.09	0.18	0.02	0.13	0.34	0.16	-0.01	-0.09	-1.01	-0.23	-0.49	-0.25	0.42	-7.22	-0.59	-0.58	-2.63	0.49	-10.06	0.52	-0.8	-2.61	-11.17	2.15	-3.77	-2.78	0.88	1.52	0.87	-8.48	0.04	-0.18	-0.04	-0.12	0.04	-0.93	-0.13
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.09	0.11	-0.18	0.29	-0.01	-0.02	-0.37	0.35	-0.11	0.36	0.12	-0.1	0.41	0.84	0.42	0.38	-0.86	-0.67	5.74	-1.02	-0.47	0.81	0.17	5.65	-0.54	-1.24	3.73	2.12	-3.98	4.41	1.79	0.77	1.15	13.16	-2.94	-8.45	-1.6	-0.05	-0.25	-0.7	-2.48	-0.54
-62	-46	-57	-467	-155	-115	-262	-554	-259	-533	-438	-579	-694	-699	-896	-808	371	-329	152	137	-22	-344	-1,078	-251	191	-72	-317	-538	892	-514	-1,210	-1,766	-1,923	-274	-477	33	-420	-158	-2,044	-3,628	-1,060	-1,031
-0.1	-0.08	-0.4	-0.36	-0.39	-0.39	-0.94	-0.56	-0.78	-0.66	-0.86	-1.28	-0.93	-0.59	-1.29	-1.32	-1.49	-2.15	4.62	-2.31	-2.01	-1.14	-2.59	3.62	-2.31	-3.49	1	-1.09	-6.42	0.2	-6.7	-2.74	-2.24	11.15	-5.28	-10.39	-4.29	-2.78	-5.49	-7.64	-7.09	-5.4
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-400.00	-521.00	-6,396.00	-400.00	-17.00	-195.00	-13.00	-	-	-11.00	-	-	-	-
-122	-144	-167	-188	-218	-260	-301	-351	-410	-488	-548	-602	-653	-728	-809	-891	-1,003	-1,145	-1,270	-1,427	-1,515	-1,599	-1,686	-1,777	-1,959	-2,174	-2,414	-2,671	-2,938	-3,183	-882	-1,342	-1,443	-1,539	-1,849	-1,974	-2,270	-2,560	-3,202	-3,309	-3,556	-3,836
0.03	0.16	-0.06	0.08	-0.02	0.14	-0.38	0.02	0.03	0.06	0.18	-0.01	-0.01	-0.17	0.13	0.08	0.29	0.31	-0.26	0.05	0.29	0.23	1.67	-2.37	1.94	1.66	4.7	-5.16	3.17	3.99	-7.33	0.59	0.94	13.62	-9.21	-5.56	0.02	2.98	2.96	0.08	-2.99	0.72
126	239.41	346.66	376.92	452.86	444.17	386.72	559.49	682.6	381.6	894.18	1,282.65	1,018.56	1,433.03	1,650.99	1,881.72	2,047.98	2,063.75	2,403.14	2,886.64	2,696.46	3,816.31	3,966.92	3,991.42	3,527.64	6,056.47	6,186.11	7,720.91	7,479	7,519	2,179	2,598	1,856	2,082	4,435	4,906	4,498	5,724	8,648	7,804	5,059	6,351
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

API Docs Get API Key

Abbott Laboratories Stock Quarterly Figures

REVENUE (B USD)

REVENUE GROWTH (%)

GROSS MARGIN (%)

GROSS INCOME (B USD)

NET INCOME (B USD)

NET INCOME GROWTH (%)

DIVIDEND (USD)DIV. (USD)

DIVIDEND GROWTH (%)DIV. GROWTH (%)

SHARES (B)

1990 Q1	1990 Q2	1990 Q3	1990 Q4	1991 Q1	1991 Q2	1991 Q3	1991 Q4	1992 Q1	1992 Q2	1992 Q3	1992 Q4	1993 Q1	1993 Q2	1993 Q3	1993 Q4	1994 Q1	1994 Q2	1994 Q3	1994 Q4	1995 Q1	1995 Q2	1995 Q3	1995 Q4	1996 Q1	1996 Q2	1996 Q3	1996 Q4	1997 Q1	1997 Q2	1997 Q3	1997 Q4	1998 Q1	1998 Q2	1998 Q3	1998 Q4	1999 Q1	1999 Q2	1999 Q3	1999 Q4	2000 Q1	2000 Q2	2000 Q3	2000 Q4	2001 Q1	2001 Q2	2001 Q3	2001 Q4	2002 Q1	2002 Q2	2002 Q3	2002 Q4	2003 Q1	2003 Q2	2003 Q3	2003 Q4	2004 Q1	2004 Q2	2004 Q3	2004 Q4	2005 Q1	2005 Q2	2005 Q3	2005 Q4	2006 Q1	2006 Q2	2006 Q3	2006 Q4	2007 Q1	2007 Q2	2007 Q3	2007 Q4	2008 Q1	2008 Q2	2008 Q3	2008 Q4	2009 Q1	2009 Q2	2009 Q3	2009 Q4	2010 Q1	2010 Q2	2010 Q3	2010 Q4	2011 Q1	2011 Q2	2011 Q3	2011 Q4	2012 Q1	2012 Q2	2012 Q3	2012 Q4	2013 Q1	2013 Q2	2013 Q3	2013 Q4	2014 Q1	2014 Q2	2014 Q3	2014 Q4	2015 Q1	2015 Q2	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1e	2026 Q2e	2026 Q3e	2026 Q4e	2027 Q1e	2027 Q2e	2027 Q3e	2027 Q4e
1.44	1.5	1.51	1.71	1.65	1.68	1.65	1.89	1.88	1.91	1.97	2.1	2.05	2.07	2.06	2.23	2.22	2.2	2.26	2.48	2.52	2.5	2.39	2.6	2.67	2.7	2.65	3	3	2.9	2.87	3.12	3.05	3.07	3.04	3.33	3.31	3.26	3.14	3.47	3.35	3.37	3.32	3.7	3.56	4.1	4.18	4.45	4.19	4.31	4.34	4.84	4.01	4.13	4.25	4.9	4.64	4.7	4.68	5.65	5.38	5.52	5.38	6.05	5.18	5.5	5.57	6.22	5.95	6.37	6.38	7.22	6.77	7.31	7.5	7.95	6.72	7.5	7.76	8.79	7.7	8.83	8.68	9.97	9.04	9.62	9.82	-7.07	5.28	5.31	5.26	5.63	5.38	4.44	4.83	5.01	4.76	5.06	5.08	5.29	4.9	5.17	5.15	5.19	4.89	5.33	5.3	5.33	6.34	6.64	6.83	7.59	7.39	7.77	7.66	7.77	7.54	7.98	8.08	8.31	7.73	7.33	8.85	10.7	10.46	10.22	10.93	11.47	11.9	11.26	10.41	10.09	9.75	9.98	10.14	10.24	9.96	10.38	10.64	10.97	10.36	11.14	11.37	11.46	11.1	12.09	12.38	12.92	12.1	12.99	13.32	13.88
–	4.52	0.27	13.47	-3.33	1.81	-1.72	14.03	-0.42	1.65	3.14	6.45	-2.39	1.37	-0.68	8.16	-0.58	-0.50	2.31	10.07	1.69	-0.95	-4.36	8.62	2.89	1.01	-1.96	13.23	0.13	-3.33	-1.21	8.83	-2.34	0.72	-1.01	9.68	-0.51	-1.63	-3.74	10.55	-3.32	0.51	-1.57	11.67	-3.91	15.17	2.00	6.31	-5.76	2.98	0.63	11.47	-17.15	2.92	2.96	15.28	-5.25	1.36	-0.45	20.76	-4.79	2.62	-2.53	12.31	-14.29	6.14	1.31	11.57	-4.37	7.15	0.09	13.24	-6.30	8.10	2.52	6.03	-15.50	11.57	3.55	13.26	-12.42	14.65	-1.71	14.90	-9.31	6.37	2.08	-171.98	-174.77	0.57	-0.92	6.99	-4.53	-17.43	8.67	3.92	-5.17	6.35	0.44	4.15	-7.43	5.57	-0.39	0.74	-5.84	9.17	-0.58	0.58	18.79	4.77	2.89	11.13	-2.62	5.10	-1.43	1.42	-2.96	5.89	1.22	2.95	-7.07	-5.15	20.81	20.87	-2.29	-2.23	6.90	4.94	3.72	-5.36	-7.52	-3.06	-3.41	2.37	1.65	0.97	-2.70	4.14	2.49	3.19	-5.61	7.57	2.04	0.79	-3.13	8.88	2.46	4.30	-6.30	7.36	2.51	4.19
52.36	53.83	51.96	52.81	53.78	53.95	53.63	55.78	55.01	54.79	54.65	56.87	54.35	57.23	55.49	57.50	56.48	57.03	54.94	57.01	56.85	56.56	55.25	58.38	56.74	57.61	55.52	58.11	55.73	58.03	56.65	59.62	57.96	57.68	54.71	56.73	56.14	56.58	49.31	56.20	55.38	54.60	54.33	54.21	53.84	51.62	51.18	53.18	54.74	49.79	52.36	50.90	55.10	55.19	54.59	55.14	55.32	56.01	54.83	53.54	53.13	52.35	50.28	53.55	58.13	56.57	57.10	53.91	56.41	55.97	55.09	56.21	56.24	57.34	55.28	60.03	56.30	58.25	56.71	56.95	56.68	59.85	56.86	59.42	57.85	59.74	60.40	78.69	55.59	56.28	53.00	55.79	54.84	51.10	53.26	53.35	52.18	54.76	54.34	56.45	57.53	57.10	57.11	57.17	56.21	57.23	56.90	55.37	51.95	52.25	58.16	56.09	58.63	57.76	58.66	58.94	58.27	58.90	58.44	58.90	57.58	55.47	55.24	58.28	57.92	51.61	59.53	58.84	58.07	56.18	55.53	54.48	55.63	55.18	54.74	55.76	55.32	55.90	56.24	55.18	56.99	56.94	55.70	57.06	58.91	54.10	52.81	50.63	54.04	50.33	49.10	47.12
0.75	0.81	0.78	0.9	0.89	0.91	0.89	1.05	1.03	1.05	1.08	1.19	1.11	1.19	1.14	1.28	1.25	1.26	1.24	1.42	1.44	1.41	1.32	1.52	1.52	1.56	1.47	1.74	1.67	1.68	1.62	1.86	1.77	1.77	1.66	1.89	1.86	1.84	1.55	1.95	1.86	1.84	1.8	2.01	1.92	2.12	2.14	2.36	2.29	2.15	2.27	2.46	2.21	2.28	2.32	2.7	2.57	2.63	2.57	3.03	2.86	2.89	2.71	3.24	3.01	3.11	3.18	3.35	3.35	3.57	3.51	4.06	3.81	4.19	4.15	4.77	3.78	4.37	4.4	5.01	4.36	5.28	4.93	5.92	5.23	5.75	5.93	-5.56	2.94	2.99	2.79	3.14	2.95	2.27	2.57	2.68	2.48	2.77	2.76	2.99	2.82	2.95	2.94	2.97	2.75	3.05	3.02	2.95	3.29	3.47	3.97	4.26	4.33	4.49	4.49	4.58	4.39	4.7	4.72	4.9	4.45	4.07	4.89	6.24	6.06	5.28	6.51	6.75	6.91	6.32	5.78	5.5	5.42	5.51	5.55	5.71	5.51	5.8	5.98	6.06	5.9	6.34	6.33	6.54	6.54	6.54	6.54	6.54	6.54	6.54	6.54	6.54
0.22	0.24	0.22	0.28	0.25	0.27	0.25	0.32	0.29	0.32	0.28	0.35	0.35	0.35	0.32	0.39	0.37	0.38	0.35	0.42	0.42	0.42	0.38	0.47	0.48	0.47	0.42	0.51	0.54	0.52	0.47	0.57	0.59	0.59	0.53	0.63	0.67	0.65	0.47	0.66	0.65	0.59	0.65	0.75	-0.22	0.53	0.63	0.61	0.85	0.59	0.72	0.63	0.8	0.25	0.76	0.94	0.82	0.63	0.8	0.98	0.84	0.88	0.68	0.98	0.86	0.61	0.72	-0.48	0.7	0.99	0.72	1.2	0.94	1.32	1.09	1.54	1.44	1.29	1.48	1.54	1	1.29	0.89	1.44	0.86	1.94	0.3	1.62	1.24	1.72	1.94	1.05	0.54	0.48	0.97	0.59	0.38	0.47	0.54	0.9	2.29	0.78	0.58	0.77	0.32	0.62	-0.33	0.8	0.42	0.28	0.6	-0.83	0.42	0.73	0.56	0.65	0.67	1.01	0.96	1.05	0.56	0.54	1.23	2.16	1.79	1.19	2.1	1.99	2.45	2.02	1.44	1.03	1.32	1.38	1.44	1.59	1.23	1.3	1.65	9.23	1.33	1.78	1.64	1.78	2.03	2.44	2.57	2.88	2.41	2.72	2.86	3.09
–	7.14	-7.92	26.70	-9.29	5.51	-5.97	25.00	-6.67	7.82	-11.99	25.09	-0.86	–	-8.67	23.73	-6.39	3.01	-6.90	20.51	-1.42	1.68	-9.91	21.73	3.23	-2.08	-10.43	21.38	4.70	-2.43	-9.77	20.38	4.06	-0.68	-9.22	17.67	6.87	-3.59	-27.44	41.88	-2.56	-8.35	10.29	15.14	-129.61	-337.22	19.28	-2.69	39.09	-30.68	21.62	-12.92	27.75	-69.29	209.35	24.05	-12.92	-22.87	26.81	21.27	-14.05	4.65	-22.35	43.32	-11.48	-29.17	16.83	-166.57	-246.64	41.69	-27.50	67.78	-22.03	40.94	-17.93	41.57	-6.32	-10.49	14.91	3.99	-34.83	28.81	-31.04	61.73	-40.11	125.03	-84.40	433.99	-23.24	38.81	12.65	-45.78	-48.34	-12.50	102.94	-39.03	-36.33	24.27	15.45	68.03	153.54	-65.79	-26.02	32.24	-58.80	94.62	-153.50	-342.55	-47.49	-32.46	113.07	-237.31	-150.48	75.36	-23.19	16.16	2.75	49.70	-4.57	9.27	-46.23	-4.79	129.42	75.49	-17.07	-33.69	76.62	-5.29	23.03	-17.53	-28.89	-28.01	27.59	4.32	4.44	11.00	-23.15	6.29	26.42	460.69	-85.64	34.26	-7.59	8.03	14.25	20.31	5.24	11.99	-16.20	12.98	4.88	8.19
0.05	0.05	0.05	0.05	0.06	0.06	0.06	0.06	0.08	-	0.08	0.08	0.09	0.09	0.09	0.09	0.10	0.10	-	-	-	0.11	0.11	0.11	0.12	0.12	0.12	0.12	0.14	0.14	0.14	0.14	0.15	0.15	0.15	0.15	0.17	0.17	0.17	0.17	0.19	0.19	0.19	0.19	0.21	0.21	0.21	0.21	0.24	0.24	0.24	0.24	0.25	0.25	0.25	0.25	0.26	0.26	0.26	0.26	0.28	0.28	0.28	0.28	0.30	0.30	0.30	0.30	0.33	0.33	0.33	0.33	0.36	0.36	0.36	0.36	0.40	0.40	0.40	0.40	0.44	0.44	0.44	0.44	0.48	0.48	0.48	0.48	0.51	0.51	0.51	0.14	0.14	0.14	0.14	0.22	0.22	0.22	0.22	0.24	0.24	0.24	0.24	0.26	0.26	0.26	0.26	0.27	0.27	0.27	0.27	0.28	0.28	0.28	0.28	0.32	0.32	0.32	0.32	0.36	0.36	0.36	0.36	0.45	0.45	0.45	0.45	0.47	0.47	0.47	0.47	0.51	0.51	0.51	0.51	0.55	0.55	0.55	0.55	0.59	0.59	0.59	0.59	0.63	-	-	-	-	-	-	-	-
–	–	–	–	20.00	–	–	–	16.67	–	–	–	28.57	–	–	–	11.11	–	–	–	–	–	–	–	20.00	–	–	–	16.67	–	–	–	7.14	–	–	–	13.33	–	–	–	11.76	–	–	–	10.53	–	–	–	9.52	–	–	–	4.35	–	–	–	8.33	–	–	–	7.69	–	–	–	3.57	–	–	–	13.79	–	–	–	9.09	–	–	–	11.11	–	–	–	10.00	–	–	–	9.09	–	–	–	6.25	–	–	-72.55	–	–	–	57.14	–	–	–	9.09	–	–	–	8.33	–	–	–	3.85	–	–	–	3.70	–	–	–	14.29	–	–	–	12.50	–	–	–	25.00	–	–	–	4.44	–	–	–	8.51	–	–	–	7.84	–	–	–	7.27	–	–	–	6.78	–	–	–	–	–	–	–	–
1.76	1.76	1.75	1.72	1.71	1.71	1.71	1.69	1.7	1.7	1.69	1.66	1.67	1.67	1.66	1.64	1.65	1.63	1.62	1.6	1.62	1.62	1.61	1.58	1.57	1.57	1.56	1.55	1.57	1.57	1.56	1.54	1.55	1.55	1.55	1.54	1.56	1.56	1.56	1.56	1.56	1.57	1.57	1.57	1.55	1.57	1.57	1.58	1.58	1.57	1.57	1.57	1.57	1.57	1.57	1.58	1.57	1.57	1.57	1.57	1.57	1.57	1.56	1.55	1.54	1.53	1.54	1.53	1.56	1.56	1.56	1.56	1.56	1.55	1.56	1.57	1.56	1.55	1.55	1.56	1.56	1.55	1.55	1.56	1.56	1.57	1.57	1.61	1.59	1.61	1.59	1.58	1.59	1.57	1.57	1.57	1.55	1.52	1.52	1.52	1.52	1.5	1.51	1.5	1.48	1.48	1.48	1.48	1.74	1.74	1.75	1.75	1.77	1.77	1.77	1.77	1.78	1.78	1.78	1.78	1.78	1.79	1.79	1.79	1.79	1.79	1.79	1.78	1.77	1.77	1.76	1.75	1.75	1.75	1.75	1.75	1.75	1.75	1.75	1.74	1.75	1.75	1.75	1.75	1.75	1.75	1.75	1.75	1.75	1.75	1.75	1.75

Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Gross Margin

EBIT and EBIT Margin

Net Income and Earnings Per Share (EPS)

Shares Outstanding

Analyst Estimates

Unlock the full history with 30+ years of data and forecast estimates.

Unlock all data — PRO

API Docs Get API Key

Abbott Laboratories stock margins

The Abbott Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Abbott Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Abbott Laboratories.

3 Years
5 Years
10 Years
25 Years
Max

Gross margin

EBIT margin

Profit margin

Details

API Docs Get API Key

Abbott Laboratories Stock Sales Revenue, EBIT, Earnings per Share

The Abbott Laboratories earnings per share therefore indicates how much revenue Abbott Laboratories has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

3 Years
5 Years
10 Years
25 Years
Max

Sales per Share

EBIT per share

Earnings per Share

Details

API Docs Get API Key

Abbott Laboratories business model

Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries.

API Docs Get API Key

Abbott Laboratories SWOT Analysis

Strengths

Abbott Laboratories possesses several key strengths that contribute to its success in the healthcare industry. These include:

Strong Market Presence: As a well-established global healthcare company, Abbott Laboratories has a wide market reach and a strong brand reputation.
Diversified Product Portfolio: With a diverse range of healthcare products, including pharmaceuticals, diagnostics, medical devices, and nutrition, Abbott Laboratories reduces its dependence on a single product or market segment.
Innovation and R&D Capabilities: The company invests significantly in research and development to drive innovation and maintain a competitive edge in introducing new products and technologies.
Financial Stability: Abbott Laboratories has a solid financial position, reflected in its consistent revenue growth and strong profitability, allowing the company to invest in expansion and acquisitions.

Weaknesses

Despite its strengths, Abbott Laboratories is also faced with certain weaknesses that could hinder its performance. These weaknesses include:

Product Recalls and Quality Control Issues: The company has experienced occasional product recalls and quality control challenges, which can damage its reputation and consumer trust.
Dependence on Third-Party Suppliers: Abbott Laboratories relies on a network of suppliers for raw materials and components, making it vulnerable to potential disruptions, such as supply chain issues or changes in supplier relationships.
Regulatory Challenges: Operating in a highly regulated industry, Abbott Laboratories faces compliance challenges and increased scrutiny from regulatory authorities, which could impact its operations and product approvals.

Opportunities

Abbott Laboratories can explore various opportunities to further enhance its market position and growth potential, such as:

Emerging Markets: Expanding into emerging markets, where there is a growing demand for healthcare products and services, presents significant opportunities for Abbott Laboratories to increase its customer base.
Technological Advancements: Investing in advanced technologies and digital health solutions can help Abbott Laboratories stay ahead in the evolving healthcare landscape and provide innovative solutions to meet changing customer needs.
Aging Population and Chronic Diseases: With the global rise in aging population and prevalence of chronic diseases, the demand for Abbott Laboratories' healthcare products and solutions is likely to increase, creating new market opportunities.

Threats

Abbott Laboratories needs to be aware of the following threats that could potentially impact its business negatively:

Intense Competition: The healthcare industry is highly competitive, with numerous local and global players. Abbott Laboratories faces the risk of losing market share to competitors who offer similar healthcare products and solutions.
Regulatory and Legal Risks: Compliance with rigorous regulations and potential legal challenges, including product liability claims, pose threats to Abbott Laboratories, requiring proactive risk management and legal expertise.
Increasing Healthcare Costs: As healthcare costs continue to rise, governments and healthcare providers may exert pressure to reduce pricing, which could impact Abbott Laboratories' profitability.

API Docs Get API Key

Abbott Laboratories Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

API Docs Get API Key

Abbott Laboratories historical P/E ratio, EBIT multiple, and P/S ratio

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Abbott Laboratories's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Abbott Laboratories's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Abbott Laboratories's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Abbott Laboratories grows earnings faster than its peers.

API Docs Get API Key

Abbott Laboratories annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

API Docs Get API Key

Abbott Laboratories shares outstanding

The number of shares was Abbott Laboratories in 2025 — This indicates how many shares 1.749 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

3 Years
5 Years
10 Years
25 Years
Max

Number of stocks

Details

API Docs Get API Key

Abbott Laboratories stock splits

In Abbott Laboratories's history, there have been no stock splits.

API Docs Get API Key

Abbott Laboratories Dividend History

37 years of dividend payments · 5 consecutive increases

YearAnnual DividendYoY ChangePayments

20260.63USDYTD—1×

Jan 15, 20260.63USD↑ 6.8%1/1

20252.36USD↑ 7.3%4×

Jan 15, 20250.59USD↑ 7.3%1/4

Apr 15, 20250.59USD 0.0%2/4

Jul 15, 20250.59USD 0.0%3/4

Oct 15, 20250.59USD 0.0%4/4

20242.2USD↑ 7.8%4×

API Docs Get API Key

Abbott Laboratories dividend history and estimates

In 2025, Abbott Laboratories paid a dividend amounting to 2.36 USD. Dividend means that Abbott Laboratories distributes a portion of its profits to its owners.

3 Years
5 Years
10 Years
25 Years
Max

Dividend

Dividend (Estimate)

Details

API Docs Get API Key

Abbott Laboratories dividend payout ratio

In 2025, Abbott Laboratories had a payout ratio of 48.63%. The payout ratio indicates the percentage of the company's profits that Abbott Laboratories distributes as dividends.

3 Years
5 Years
10 Years
25 Years
Max

Payout ratio

Details

API Docs Get API Key

Current Abbott Laboratories forecasts and price targets in March 2026

Δ MOM Price Target	6.90 %
Buy	71.43 % (25)
Hold	28.57 % (10)
Sell	null % (0)
12M Price Target	137.70
Last Price	108.66
Currency	USD
12M Return Potential	26.73 %
LTM Return	0 %

API Docs Get API Key

Abbott Laboratories Earnings Calls

2025

Oct 15Q3 2025 Earnings Call Transcript

Audio PRO

Jul 17Q2 2025 Earnings Call Transcript

Audio PRO

Apr 16Q1 2025 Earnings Call Transcript

Audio PRO

Jan 22Q4 2024 Earnings Call Transcript

Audio PRO

2024

Oct 16Q3 2024 Earnings Call Transcript

Audio PRO

Jul 18Q2 2024 Earnings Call Transcript

Audio PRO

Apr 17Q1 2024 Earnings Call Transcript

Audio PRO

Jan 24Q4 2023 Earnings Call Transcript

Audio PRO

2023

Oct 18Q3 2023 Earnings Call Transcript

Audio PRO

Jul 20Q2 2023 Earnings Call Transcript

Audio PRO

Apr 19Q1 2023 Earnings Call Transcript

Audio PRO

Jan 25Q4 2022 Earnings Call Transcript

Audio PRO

Unlock Earnings — PRO

Abbott Laboratories Earnings Estimates

Date	EPS estimate	Revenue Estimate	Quarterly report
1/22/2026	1.51USD	11.92 BUSD	2025 Q4
1/20/2026	1.51USD	11.92 BUSD	2025 Q4
4/17/2024	1.05USD	9.91 BUSD	2024 Q1
1/23/2024	1.2USD	10.28 BUSD	2023 Q4
7/18/2023	1.1USD	9.99 BUSD	2023 Q2
4/18/2023	1.01USD	9.55 BUSD	2023 Q1
1/24/2023	0.92USD	9.78 BUSD	2022 Q4
10/19/2022	0.95USD	9.82 BUSD	2022 Q3
7/20/2022	1.14USD	10.47 BUSD	2022 Q2
4/20/2022	1.48USD	11.15 BUSD	2022 Q1
1/26/2022	1.22USD	10.87 BUSD	2021 Q4
10/20/2021	0.95USD	9.7 BUSD	2021 Q3
7/22/2021	1.03USD	9.84 BUSD	2021 Q2
4/20/2021	1.29USD	10.85 BUSD	2021 Q1
1/27/2021	1.37USD	10.08 BUSD	2020 Q4
10/21/2020	0.92USD	8.67 BUSD	2020 Q3
7/16/2020	0.43USD	6.91 BUSD	2020 Q2
4/16/2020	0.59USD	7.45 BUSD	2020 Q1
1/22/2020	0.96USD	8.39 BUSD	2019 Q4
10/16/2019	0.85USD	8.23 BUSD	2019 Q3
7/17/2019	0.81USD	8.12 BUSD	2019 Q2
4/17/2019	0.62USD	7.59 BUSD	2019 Q1
1/23/2019	0.82USD	7.93 BUSD	2018 Q4
10/17/2018	0.75USD	7.77 BUSD	2018 Q3
7/18/2018	0.72USD	7.83 BUSD	2018 Q2
4/18/2018	0.59USD	7.4 BUSD	2018 Q1
1/24/2018	0.74USD	7.5 BUSD	2017 Q4
10/18/2017	0.66USD	6.82 BUSD	2017 Q3
7/20/2017	0.61USD	6.73 BUSD	2017 Q2
4/19/2017	0.43USD	6.24 BUSD	2017 Q1
1/25/2017	0.65USD	5.46 BUSD	2016 Q4
10/19/2016	0.59USD	5.37 BUSD	2016 Q3
7/20/2016	0.54USD	5.32 BUSD	2016 Q2
4/20/2016	0.4USD	4.85 BUSD	2016 Q1
1/28/2016	0.62USD	5.31 BUSD	2015 Q4
10/21/2015	0.54USD	5.22 BUSD	2015 Q3
7/22/2015	0.51USD	5.23 BUSD	2015 Q2
4/22/2015	0.42USD	4.92 BUSD	2015 Q1
1/29/2015	0.69USD	5.5 BUSD	2014 Q4
10/22/2014	0.6USD	5.68 BUSD	2014 Q3
7/16/2014	0.51USD	5.61 BUSD	2014 Q2
4/16/2014	0.36USD	5.35 BUSD	2014 Q1
1/22/2014	0.59USD	5.8 BUSD	2013 Q4
10/16/2013	0.52USD	5.48 BUSD	2013 Q3
7/17/2013	0.45USD	5.6 BUSD	2013 Q2
4/17/2013	0.42USD	5.49 BUSD	2013 Q1
1/23/2013	1.51USD	10.74 BUSD	2012 Q4
10/17/2012	1.3USD	10.09 BUSD	2012 Q3
7/18/2012	1.23USD	9.99 BUSD	2012 Q2
4/18/2012	1.01USD	9.51 BUSD	2012 Q1
1/25/2012	1.45USD	10.79 BUSD	2011 Q4
10/19/2011	1.18USD	9.78 BUSD	2011 Q3
7/20/2011	1.12USD	9.72 BUSD	2011 Q2
4/20/2011	0.91USD	8.96 BUSD	2011 Q1
1/26/2011	1.3USD	10.04 BUSD	2010 Q4
10/20/2010	1.05USD	9.05 BUSD	2010 Q3
7/21/2010	1.01USD	8.97 BUSD	2010 Q2
4/21/2010	0.81USD	7.85 BUSD	2010 Q1
1/27/2010	1.18USD	8.73 BUSD	2009 Q4
10/14/2009	0.91USD	7.87 BUSD	2009 Q3
7/15/2009	0.9USD	7.67 BUSD	2009 Q2
4/15/2009	0.71USD	7.17 BUSD	2009 Q1
1/21/2009	1.07USD	8.11 BUSD	2008 Q4
10/15/2008	0.78USD	7.46 BUSD	2008 Q3
7/16/2008	0.79USD	7.34 BUSD	2008 Q2
4/16/2008	0.63USD	6.63 BUSD	2008 Q1
1/23/2008	0.93USD	7.07 BUSD	2007 Q4
10/17/2007	0.67USD	6.34 BUSD	2007 Q3
7/18/2007	0.68USD	5.59 BUSD	2007 Q2
4/18/2007	0.53USD	5.34 BUSD	2007 Q1
1/24/2007	0.75USD	6.27 BUSD	2006 Q4
10/18/2006	0.59USD	5.56 BUSD	2006 Q3
7/19/2006	0.58USD	5.54 BUSD	2006 Q2
4/19/2006	0.58USD	5.38 BUSD	2006 Q1
1/25/2006	0.77USD	6.26 BUSD	2005 Q4
10/19/2005	0.58USD	5.46 BUSD	2005 Q3
7/13/2005	0.58USD	5.36 BUSD	2005 Q2
4/12/2005	0.59USD	5.36 BUSD	2005 Q1
1/18/2005	0.67USD	5.47 BUSD	2004 Q4
10/14/2004	0.53USD	4.73 BUSD	2004 Q3
7/9/2004	0.55USD	4.71 BUSD	2004 Q2
4/8/2004	0.57USD	5.1 BUSD	2004 Q1
1/16/2004	0.66USD	5.38 BUSD	2003 Q4
10/9/2003	0.54USD	4.78 BUSD	2003 Q3
7/10/2003	0.52USD	4.7 BUSD	2003 Q2
4/9/2003	0.51USD	4.56 BUSD	2003 Q1
1/16/2003	0.56USD	4.82 BUSD	2002 Q4
10/9/2002	0.49USD	4.46 BUSD	2002 Q3
7/11/2002	0.5USD	4.4 BUSD	2002 Q2
4/9/2002	0.55USD	4.35 BUSD	2002 Q1
1/16/2002	0.52USD	4.62 BUSD	2001 Q4
10/10/2001	0.44USD	3.97 BUSD	2001 Q3
7/12/2001	0.45USD	4.02 BUSD	2001 Q2

...

EESG©

Eulerpool ESG Scorecard© for the Abbott Laboratories stock

80/100

Environment

Social

Governance

Environment

Scope 1 - Direct Emissions510,000

Scope 2 - Indirect emissions from purchased energy471,000

Scope 3 - Indirect emissions within the value chain10,665,000

Total CO₂ emissions981,000

CO₂ reduction strategy

Coal energy

Nuclear power

Animal experiments

Fur & Leather—

Pesticides—

Palm Oil—

Tobacco

Genetically modified organisms

Climate concept—

Sustainable forestry—

Recycling regulations

Environmentally friendly packaging

Hazardous substances

Fuel consumption and efficiency

Water consumption and efficiency

Social

Percentage of female employees46

Percentage of women in management—

Percentage of Asian employees20.2

Share of Asian management20.7

Percentage of Hispanic/Latino employees11.6

Hispano/Latino Management share7.2

Percentage of Black employees9.2

Black Management Share4.6

Percentage of white employees56

White Management Share64.9

Adult content

Alcohol

Weapons—

Firearms

Gambling

Military contracts

Human rights concept

Privacy concept—

Occupational health and safety

Catholic

Governance (Corporate Governance)

Environmental reporting

Stakeholder Engagement

Call Back Policies

Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

API Docs Get API Key

Abbott Laboratories shareholders

%	Name	Stocks	Change	Date
9.83569%	The Vanguard Group, Inc.	172,026,172	+2,957,530	6/30/2025
5.06092%	BlackRock Institutional Trust Company, N.A.	88,515,569	+696,109	6/30/2025
4.47995%	State Street Investment Management (US)	78,354,270	+689,517	6/30/2025
3.43835%	Capital International Investors	60,136,663	-6,687,339	6/30/2025
2.38800%	Capital Research Global Investors	41,766,185	-8,968,261	6/30/2025
2.18943%	Geode Capital Management, L.L.C.	38,293,067	+1,390,554	6/30/2025
1.50834%	JP Morgan Asset Management	26,380,953	-2,416,685	6/30/2025
1.43228%	Wellington Management Company, LLP	25,050,579	-4,712,836	6/30/2025
1.27214%	Norges Bank Investment Management (NBIM)	22,249,689	+1,266,040	6/30/2025
0.86788%	Wells Fargo Advisors	15,179,239	-240,504	6/30/2025
0.83530%	MFS Investment Management	14,609,320	+762,785	9/30/2025
0.80280%	State Farm Insurance Companies	14,040,893	-91,900	6/30/2025
0.75696%	BlackRock Asset Management Ireland Limited	13,239,152	+732,045	6/30/2025
0.75340%	Charles Schwab Investment Management, Inc.	13,177,029	+87,703	6/30/2025
0.74041%	BofA Global Research (US)	12,949,833	+869,035	6/30/2025
0.73410%	BlackRock Investment Management (UK) Ltd.	12,839,373	+998,064	6/30/2025
0.72209%	Columbia Threadneedle Investments (US)	12,629,327	+1,000,892	6/30/2025
0.71996%	Fidelity Management & Research Company LLC	12,592,057	+2,759,367	6/30/2025
0.71748%	Northern Trust Investments, Inc.	12,548,800	-74,752	6/30/2025
0.68815%	Legal & General Investment Management Ltd.	12,035,787	+350,100	6/30/2025
0.67826%	Fisher Investments	11,862,823	+209,610	6/30/2025
0.67429%	Goldman Sachs Asset Management, L.P.	11,793,307	+1,560,824	6/30/2025
0.61003%	Polen Capital Management, LLC	10,669,498	-716,079	6/30/2025
0.56515%	Nuveen LLC	9,884,499	-274,995	6/30/2025
0.53456%	Parametric Portfolio Associates LLC	9,349,535	+386,625	6/30/2025
0.50792%	Capital World Investors	8,883,526	-122,463	6/30/2025
0.50605%	Dimensional Fund Advisors, L.P.	8,850,834	-216,144	6/30/2025
0.50004%	Managed Account Advisors LLC	8,745,645	+104,935	6/30/2025
0.49619%	UBS Financial Services, Inc.	8,678,373	-740,966	6/30/2025
0.47837%	T. Rowe Price Investment Management, Inc.	8,366,739	+413,347	6/30/2025
0.45617%	BlackRock Financial Management, Inc.	7,978,402	+119,805	6/30/2025
0.45516%	Morgan Stanley Smith Barney LLC	7,960,673	+197,031	6/30/2025
0.44680%	Grantham Mayo Van Otterloo & Co LLC	7,814,538	-293,045	6/30/2025
0.44616%	T. Rowe Price Associates, Inc.	7,803,363	+6,158,607	6/30/2025
0.41191%	Mellon Investments Corporation	7,204,226	-82,299	6/30/2025
0.40408%	Morgan Stanley Investment Management Ltd. (UK)	7,067,365	-1,454,534	6/30/2025
0.38474%	Starks (Daniel J)	6,729,075	+1,635	4/25/2025
0.38469%	DWS Investment GmbH	6,728,226	-560,304	6/30/2025
0.38210%	Franklin Advisers, Inc.	6,682,901	+107,205	6/30/2025
0.36723%	Flossbach von Storch AG	6,422,870	-528,626	6/30/2025
0.34098%	Mitsubishi UFJ Asset Management Co., Ltd.	5,963,729	-557,183	6/30/2025
0.33807%	Diamond Hill Capital Management Inc.	5,912,808	-160,957	6/30/2025
0.33247%	Envestnet Asset Management, Inc.	5,814,931	+177,700	6/30/2025
0.30499%	Northern Trust Global Investments	5,334,245	-128,032	6/30/2025
0.30268%	Amundi Asset Management, SAS	5,293,911	+18,270	6/30/2025
0.30016%	Schweizerische Nationalbank	5,249,880	+358,100	6/30/2025
0.29865%	Janus Henderson Investors	5,223,429	-79,823	6/30/2025
0.29823%	JPMorgan Private Bank (United States)	5,216,123	-7,207	6/30/2025
0.28467%	Neuberger Berman, LLC	4,978,899	+641,146	6/30/2025
0.28151%	Morgan Stanley & Co. LLC	4,923,524	-282,530	6/30/2025
0.26688%	BlackRock (Netherlands) B.V.	4,667,750	-330,594	6/30/2025
0.26374%	California Public Employees' Retirement System	4,612,836	-1,224,614	6/30/2025
0.26296%	Vontobel Asset Management, Inc.	4,599,212	-1,362,715	9/30/2025
0.25856%	Fayez Sarofim & Co.	4,522,297	-99,447	6/30/2025
0.24720%	Union Investment Privatfonds GmbH	4,323,556	-106,647	6/30/2025
0.24327%	Principal Global Investors (Equity)	4,254,863	+131,388	6/30/2025
0.23961%	Sumitomo Mitsui Trust Bank, Limited	4,190,759	+52,220	9/30/2025
0.23546%	CIBC Private Wealth Management	4,118,212	+112,388	6/30/2025
0.22809%	Citi Investment Research (US)	3,989,373	-90,422	6/30/2025
0.22535%	Invesco Capital Management LLC	3,941,324	+471,823	6/30/2025
0.22196%	UBS Asset Management (UK) Ltd.	3,882,156	+781,772	6/30/2025
0.21728%	BlackRock Investment Management, LLC	3,800,189	+1,735,484	6/30/2025
0.21403%	Aperio Group, LLC	3,743,342	+343,749	6/30/2025
0.21327%	PNC Investments LLC	3,730,142	-27,613	6/30/2025
0.21071%	UBS Asset Management (Switzerland)	3,685,396	+1,015,639	6/30/2025
0.20930%	AllianceBernstein L.P.	3,660,656	-168,803	6/30/2025
0.20274%	Allianz Global Investors GmbH	3,545,960	+596,750	6/30/2025
0.19865%	UBS Asset Management (Americas) LLC	3,474,382	+278,443	6/30/2025
0.19833%	National Pension Service	3,468,778	-135,250	6/30/2025
0.19286%	BNY Mellon Asset Management	3,373,122	-563,472	6/30/2025
0.19084%	BNP Paribas Securities Corp. North America	3,337,867	-169,902	6/30/2025
0.18831%	Raymond James & Associates, Inc.	3,293,517	+20,251	6/30/2025
0.18740%	Ensign Peak Advisors, Inc.	3,277,679	+170,122	6/30/2025
0.17867%	Wellcome Trust	3,125,000		6/30/2025
0.17687%	Rhumbline Advisers Ltd. Partnership	3,093,462	-53,460	6/30/2025
0.17673%	HSBC Global Asset Management (UK) Limited	3,090,952	-196,689	6/30/2025
0.17515%	First Trust Advisors L.P.	3,063,443	+1,972,097	6/30/2025
0.17118%	BlackRock Japan Co., Ltd.	2,994,009	-101,491	6/30/2025
0.16902%	TD Asset Management Inc.	2,956,122	+1,519,452	6/30/2025
0.16562%	Acadian Asset Management LLC	2,896,714	+1,309,523	6/30/2025
0.16446%	Rathbones Investment Management Limited	2,876,482	+178,946	6/30/2025
0.16410%	U.S. Bancorp Asset Management, Inc.	2,870,124	-50,033	6/30/2025
0.16285%	RBC Capital Markets Wealth Management	2,848,226	+195,296	6/30/2025
0.16054%	Manulife Investment Management (North America) Limited	2,807,844	-155,312	6/30/2025
0.16044%	J.P. Morgan Securities LLC	2,806,107	+30,576	6/30/2025
0.16032%	DWS Investments UK Limited	2,804,015	+210,541	6/30/2025
0.15654%	California State Teachers Retirement System	2,737,865	-9,466	6/30/2025
0.14558%	T. Rowe Price International Ltd	2,546,152	+20,385	6/30/2025
0.14521%	Goldman Sachs & Company, Inc.	2,539,805	-2,041,265	6/30/2025
0.13886%	Boston Management and Research	2,428,595	+108,193	6/30/2025
0.13600%	Jensen Investment Management Inc.	2,378,563	+1,012,778	6/30/2025
0.13405%	PGIM Quantitative Solutions LLC	2,344,546	+614,018	6/30/2025
0.13359%	Nuveen Asset Management, LLC	2,336,448	-4,469	6/30/2025
0.12943%	Invesco Advisers, Inc.	2,263,714	+149,497	6/30/2025
0.12725%	Barclays Bank PLC	2,225,604	-393,570	6/30/2025
0.12566%	INVESCO Asset Management (Japan) Ltd.	2,197,829	+157,646	6/30/2025
0.12482%	Northern Trust Global Investments Limited	2,183,114	-286,938	6/30/2025
0.12339%	Jarislowsky Fraser, Ltd.	2,158,089	-37,740	9/30/2025
0.12308%	Corient Private Wealth LLC	2,152,694	+203,617	6/30/2025
0.12296%	New York State Common Retirement Fund	2,150,543	-18,885	6/30/2025

...

API Docs Get API Key

Abbott Laboratories Executives and Management Board

Mr. Robert Ford

(51)

Chairman of the Board, Chief Executive Officer · since 2014

Compensation22.78 MUSD

Compensation22.78 M USD

Mr. Philip Boudreau

(52)

Chief Financial Officer, Executive Vice President - Finance

8.23 MUSD

Compensation8.23 M USD

Mr. Hubert Allen

(59)

Executive Vice President, General Counsel, Secretary

7.98 MUSD

Compensation7.98 M USD

Ms. Lisa Earnhardt

(55)

Executive Vice President, Group President - Medical Devices

6.56 MUSD

Compensation6.56 M USD

Ms. Andrea Wainer

(56)

Executive Vice President - Rapid and Molecular Diagnostics

6.29 MUSD

Compensation6.29 M USD

API Docs Get API Key

Abbott Laboratories Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite

30 companies

#	Name	1M	3M	6M	1Y	2Y
1	Medicover B	0,48	0,72	0,93	0,83	0,87
2	Allergy Therapeutics Supplier	0,40	0,49	0,87	0,56	0,76
3	Stagwell A Supplier	0,36	0,30	0,71	0,55	0,74
4	discoverIE Group plc Supplier	0,59	0,79	0,92	0,48	0,72
5	Kolon Corporation	0,36	0,74	0,85	0,23	0,68

#	Name	1M	3M	6M	1Y	2Y
1	Apria, Inc.	-0,14	-0,62	-0,55	-0,19	—
2	ON24 Supplier	0,69	0,85	0,91	-0,16	—
3	Next Fifteen Comm Supplier	0,80	0,46	-0,10	0,19	—
4	Certara Supplier	0,79	0,78	0,90	0,42	—
5	Ilyang Pharmaceutical Co.,Ltd	0,80	0,75	0,65	-0,05	-0,74

API Docs Get API Key

Abbott Laboratories Research

Soon

Deep-dive analyses, investment theses, and proprietary research — curated by Eulerpool.

Research reports are coming soon

We're building institutional-grade equity research for Abbott Laboratories and thousands of other companies.

Most common questions regarding Abbott Laboratories

Abbott Laboratories is a renowned healthcare company with a strong business model focused on providing a diverse range of medical products, diagnostics, nutritional supplements, and pharmaceuticals. By combining technological advancements with innovative research, Abbott aims to enhance the quality of life for individuals worldwide. With a comprehensive portfolio spanning diverse healthcare sectors, including diagnostics, nutrition, diabetes care, medical devices, and branded generic pharmaceuticals, Abbott Laboratories strives to improve patient outcomes and deliver sustainable growth. Through its commitment to scientific excellence and dedication to meeting evolving healthcare needs, Abbott Laboratories has established itself as a trusted leader in the global healthcare industry.

API Docs Get API Key

Fair ValuePRO

94.35 USD

Over-/UndervaluationPRO

24.0% undervalued

Expected Return

13.86 %

Sector

Health

Industry

Health Care Equipment

Number of shares

1,749,000,000

Employees

109,000

Revenue per Employee

406,678.9 USD

Revenue growth Ø5 years

0.58 %

EBIT growth Ø5 years

0.06 %

Net Income growth Ø5 years

-1.6 %

Website abbott.com

Country

United States 🇺🇸

Currency

USD

Initial public offering

Mar 1, 1937

ISIN

US0028241000

Cusip

002824100

Sedol

2002305

Market capitalization

197 B USDLarge Cap

52-Week Range

108.67–116.27USD

Abbott Laboratories Directors Dealings

Quality Investing

Details

6 / 10

Sales growth (10Y) > 5%

Revenue growth (3Y) > 5 %

EBIT growth (10Y) > 5%

EBIT growth (3Y) > 5 %

Net debt < 4x EBIT

Profitable since 10Y+

EBIT Drawdown (10Y) < 50%

Return on Equity (ROE) > 15%

ROCE > 15%

Return Expectation > 10%

PEG

3.78

P/E ratio

30.85

P/Ee 2026

20.04

P/Ee 2027

18.21

P/Ee 2028

16.64

P/Ee 2029

15.5

P/Ee 2030

13.63

P/S

4.54

P/Se

4.17

EV/EBIT

22.87

P/B Ratio

4.13

ROE (Return on Equity)

28.12 %

ROA (Return on Assets)

16.46 %

ROCE (Return on Capital Employed)

14.67 %

ROIC (Return on Invested Capital)

12.91 %

PROUnlock all valuation metrics

Gross Margin

56.72 %

EBIT Margin

19.43 %

Net Margin

14.72 %

EPS (Earnings Per Share)

3.73 USD

Net Debt / EBIT

—

Debt/Equity

0.3

Dividend

2.36 USD

Dividend yield

2.05 %

Est. Dividend Yield

0.55 %

Payout Ratio

48.63 %

Dividend growth Ø5Y

5.57 %

Dividend payments per year

Dividend paid since

36 years+

Dividend not reduced since

5 years

Dividend increased since

5 years

Dividend withholding tax

30 %

Last updated Mar 7, 2026, 7:04 AM

Abbott Laboratories Presentations

Abbott Laboratories Peer Group

Becton Dickinson and Co

Boston Scientific Corp

Intuitive Surgical IncPRO

Stryker CorpPRO

Edwards Lifesciences CorpPRO

Danaher CorpPRO

Abbott Laboratories Ticker

DÜSSELDORF · ABL.DUFRANKFURT · ABL.FHAMBURG · ABL.HMLONDON · 0Q15.LMUNICH · ABL.MUNEW YORK · ABTSIX · ABT.SWVIENNA · ABT.VIXETRA · ABL.DE

Abbott Laboratories FIGI

ABT:US · BBG000B9ZXB4ABT:UA · BBG000B9ZXW1ABT:UC · BBG000B9ZY95ABT:UN · BBG000B9ZZG4ABT:UP · BBG000B9ZZT0ABT:UB · BBG000BB00T0ABT:UT · BBG000BB0181ABT:UM · BBG000BB01J9ABT:UX · BBG000BB0216ABT:UD · BBG000BB04T2ABT:UF · BBG000BB0699ABT:VY · BBG000BB06M4ABT:VJ · BBG000BB06X2ABT:VK · BBG000BB07G9ABT:SW · BBG000BN5WF4ABT:SE · BBG000BN5X26ABL:GR · BBG000H2RD53ABL:GF · BBG000H2RDP1ABL:GD · BBG000H2RFM9ABL:GY · BBG000H2RGK9ABL:GS · BBG000H2SJ04ABL:GM · BBG000H2SJW9ABL:GB · BBG000H2SL90ABL:GI · BBG000H2SMX1ABL:GH · BBG000H2SNT4ABT*:MM · BBG000L47866ABT*:MF · BBG000L478Y5ABT:EO · BBG000NCDNN7ABT:XH · BBG000NCFRZ3ABT:XC · BBG000NCFS90ABT:XF · BBG000NCFSR0ABT:XE · BBG000NCFV57ABT:XJ · BBG000NCFVN7ABT:XL · BBG000NCFVR3ABT:XG · BBG000NCFVV8ABT:XO · BBG000NCFW37ABT:XS · BBG000NCFXW3ABT:XA · BBG000NCFY79ABT:E1 · BBG000NCFYQ8ABT:XT · BBG000NCFZT2ABT:XW · BBG000NCG036ABT:EU · BBG000NCG0Y2ABTEUR:EU · BBG000NGZZG5ABTEUR:EO · BBG000NJPNK2ABTEUR:E1 · BBG000NJR0Q4ABTEUR:XT · BBG000NJR1F4ABTEUR:XW · BBG000NJR280ABTN:TQ · BBG000RFRN97ABL:TH · BBG000RZ1H49ABTCHF:EO · BBG001KWXL38ABTCHF:E1 · BBG001KWXLN6ABTCHF:XT · BBG001KWXLP4ABTCHF:XW · BBG001KWXLQ3ABTCHF:EU · BBG001KWXLS1ABT:CI · BBG004BWL442ABT:CC · BBG004BWL451ABT:XV · BBG00591KV78ABTCHF:XV · BBG00591ZGM8ABT:BW · BBG006M6Y1D4ABTL:B3 · BBG006T7TSC3ABTL:L3 · BBG006TC5048ABL:QT · BBG0077H4674ABTL:PO · BBG008GZ8S25ABTN:PO · BBG008GZ8S43ABT:VF · BBG00DJCT5J1ABL:GZ · BBG00FGX08Z0ABT:XX · BBG00JN7HH01ABTEUR:XX · BBG00JN7KYZ2ABTCHF:XX · BBG00JN7X3M0ABTGBX:X2 · BBG00JRQNRH8ABTGBX:XB · BBG00JRQNRJ6ABTGBX:XH · BBG00JRQNRL3ABTGBX:XF · BBG00JRQNRN1ABTGBX:XE · BBG00JRQNRQ8ABTGBX:XJ · BBG00JRQNRR7ABTGBX:XL · BBG00JRQNRS6ABTGBX:XG · BBG00JRQNRT5ABTGBX:XO · BBG00JRQNRV2ABTGBX:XS · BBG00JRQNRZ8ABTGBX:XA · BBG00JRQNS04ABTGBX:E1 · BBG00JRQNS13ABTGBX:XT · BBG00JRQNS22ABTGBX:XW · BBG00JRQNS31ABTGBX:XU · BBG00JRQNS40ABTGBX:XV · BBG00JRQNS59ABTGBX:XM · BBG00JRQNS68ABTGBX:XQ · BBG00JRQNS86ABTGBX:XX · BBG00JRQNS95ABTGBX:XZ · BBG00JRQNSB2ABTGBX:EU · BBG00JRQNSD0ABT*:MU · BBG00JX0P6460Q15:LN · BBG00K9Q6546ABT:AV · BBG00KTDT9Q6ABTRUB:EP · BBG00VC79BJ8ABTRUB:EZ · BBG00VC79BQ0ABTRUB:XS · BBG00VC79BR9ABTRUB:X2 · BBG00VC79BS8ABTRUB:XH · BBG00VC79BV4ABTRUB:XF · BBG00VC79BX2ABTRUB:XE · BBG00VC79BZ0ABTRUB:XJ · BBG00VC79C06ABTRUB:XL · BBG00VC79C15ABTRUB:XG · BBG00VC79C24ABTRUB:XO · BBG00VC79C33ABTRUB:XA · BBG00VC79C79ABTRUB:E1 · BBG00VC79C88ABTRUB:XT · BBG00VC79C97ABTRUB:XW · BBG00VC79CB4ABTRUB:XU · BBG00VC79CC3ABTRUB:XV · BBG00VC79CF0ABTRUB:XM · BBG00VC79CG9ABTRUB:XQ · BBG00VC79CH8ABTRUB:XX · BBG00VC79CJ6ABTRUB:XZ · BBG00VC79CK4ABTRUB:X1 · BBG00VC79CM2ABTRUB:EU · BBG00VC79CP9ABT:VP · BBG00X1PKZZ2ABTN:L1 · BBG00Y7B8L44ABT-RM:RM · BBG00YCLP356ABT-RM:RX · BBG00YCLP365ABT-RM:RN · BBG00YCLP374ABT-RM:RP · BBG00YCLP383ABTCL:CI · BBG00YFSB0P7ABTCL:CC · BBG00YFSB0Q6ABTCL:CE · BBG00YFSB0R5ABT_KZ:KZ · BBG013NQ3ZZ0ABL:LA · BBG018H7TJX8ABL:LU · BBG018J1GMJ2ABL:BU · BBG01BPF38G5ABLD:PO · BBG01FT4JV06ABLD:B3 · BBG01FT4JXR3ABLD:L1 · BBG01FT4K011ABLD:L3 · BBG01FT4K1L7ABLD:EB · BBG01FT57XC9ABLD:IX · BBG01FT59C97ABLD:I2 · BBG01FT59XX4ABLD:S1 · BBG01FY4PN83ABLD:S4 · BBG01FY4PP15

All fundamentals about Abbott Laboratories

Our stock analysis for Abbott Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbott Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Abbott Laboratories Revenue→

Abbott Laboratories Net Income→

Abbott Laboratories P/E→

Abbott Laboratories P/S→

Abbott Laboratories EBIT→

Abbott Laboratories Dividend→

Abbott Laboratories Directors Dealings→

Abbott Laboratories Stocks→

Abbott Laboratories Market capitalization→

Abbott Laboratories Debt→

Abbott Laboratories Liabilities→

Abbott Laboratories Equity→